Hemodynamic support by left ventricular assist devices reduces cardiomyocyte DNA content in the failing human heart

Circulation

Volumn 121, Issue 8, 2010, Pages 989-996

  Wohlschlaeger, Jeremias ^a   Levkau, Bodo ^a   Brockhoff, Gero ^b   Schmitz, Klaus Jürgen ^a   Von Winterfeld, Moritz ^a   Takeda, Atsushi ^c   Takeda, Nobuakira ^d   Stypmann, Jörg ^e   Vahlhaus, Christian ^e   Schmid, Christof ^e   Pomjanski, Natalia ^f   Böcking, Alfred ^f   Baba, Hideo Andreas ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c GUNMA PAZ UNIVERSITY   (Japan)

^d JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^f HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Heart failure; Heart assist devices; Hypertrophy; Pathology; Remodeling

Indexed keywords

DNA;

ADULT; ARTICLE; CELL NUCLEUS; CLINICAL ARTICLE; DIPLOIDY; DNA CONTENT; DNA DETERMINATION; FEMALE; FLOW CYTOMETRY; HEART ASSIST DEVICE; HEART FAILURE; HEART LEFT VENTRICLE; HEART MUSCLE CELL; HEMODYNAMICS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE CYTOMETRY; IN SITU HYBRIDIZATION; MALE; MORPHOMETRICS; PRIORITY JOURNAL;

ADOLESCENT; ADULT; CELL COUNT; CELL CYCLE; CELL NUCLEUS; CHILD; CHILD, PRESCHOOL; DNA; FEMALE; HEART FAILURE; HEART VENTRICLES; HEART-ASSIST DEVICES; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; MYOCYTES, CARDIAC; PLOIDIES; REGENERATION; VENTRICULAR REMODELING; YOUNG ADULT;

EID: 77649253431     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.108.808071     Document Type: Article

References (27)

1. Anversa P, Kajstura J. Ventricular myocytes are not terminally differentiated in the adult mammalian heart. Circ Res. 1998;83:1-14.
2. Beltrami AP, Urbanek K, Kajstura J, Yan SM, Finato N, Bussani R, Nadal-Ginard B, Silvestri F, Leri A, Beltrami CA, Anversa P. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med. 2001;344:1750-1757.
3. Meckert PC, Rivello HG, Vigliano C, Gonzalez P, Favaloro R, Laguens R. Endomitosis and polyploidization of myocardial cells in the periphery of human acute myocardial infarction. Cardiovasc Res. 2005;67: 116-123.
4. Setoguchi M, Leri A, Wang S, Liu Y, De LA, Giordano A, Hintze TH, Kajstura J, Anversa P. Activation of cyclins and cyclin-dependent kinases, DNA synthesis, and myocyte mitotic division in pacing-induced heart failure in dogs. Lab Invest. 1999;79:1545-1558.
5. Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S, Kasahara H, Rota M, Musso E, Urbanek K, Leri A, Kajstura J, Nadal-Ginard B, Anversa P. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell. 2003;114:763-776.
6. Leri A, Kajstura J, Anversa P. Cardiac stem cells and mechanisms of myocardial regeneration. Physiol Rev. 2005;85:1373-1416.
7. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, Pickel J, McKay R, Nadal-Ginard B, Bodine DM, Leri A, Anversa P. Bone marrow cells regenerate infarcted myocardium. Nature. 2001;410: 701-705.
8. Hsieh PC, Segers VF, Davis ME, MacGillivray C, Gannon J, Molkentin JD, Robbins J, Lee RT. Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury. Nat Med. 2007;13:970-974.
9. Zafeiridis A, Jeevanandam V, Houser SR, Margulies KB. Regression of cellular hypertrophy after left ventricular assist device support. Circulation. 1998;98:656-662.
10. Baba HA, Grabellus F, August C, Plenz G, Takeda A, Tjan TD, Schmid C, Deng MC. Reversal of metallothionein expression is different throughout the human myocardium after prolonged left-ventricular mechanical support. J Heart Lung Transplant. 2000;19:668-674.
11. Wohlschlaeger J, Schmitz KJ, Schmid C, Schmid KW, Keul P, Takeda A, Weis S, Levkau B, Baba HA. Reverse remodeling following insertion of left ventricular assist devices (LVAD): a review of the morphological and molecular changes. Cardiovasc Res. 2005;68:376-386.
12. Rivello HG, Meckert PC, Vigliano C, Favaloro R, Laguens RP. Cardiac myocyte nuclear size and ploidy status decrease after mechanical support. Cardiovasc Pathol. 2001;10:53-57.
13. Brockhoff G, Fleischmann S, Meier A, Wachs FP, Hofstaedter F, Knuechel R. Use of a mechanical dissociation device to improve standardization of flow cytometric cytokeratin DNA measurements of colon carcinomas. Cytometry. 1999;38:184-191.
14. Engel FB, Hsieh PC, Lee RT, Keating MT. FGF1/p38 MAP kinase inhibitor therapy induces cardiomyocyte mitosis, reduces scarring, and rescues function after myocardial infarction. Proc Natl Acad Sci USA. 2006;103:15546-115451
15. Engel FB, Schebesta M, Duong MT, Lu G, Ren S, Madwed JB, Jiang H, Wang Y, Keating MT. p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes. Genes Dev. 2005;19:1175-1187.
16. Woo YJ, Panlilio CM, Cheng RK, Liao GP, Suarez EE, Atluri P, Chaudhry HW. Myocardial regeneration therapy for ischemic cardiomy-opathy with cyclin A2. J Thorac Cardiovasc Surg. 2007;133:927-933.
17. Woo YJ, Panlilio CM, Cheng RK, Liao GP, Atluri P, Hsu VM, Cohen JE, Chaudhry HW. Therapeutic delivery of cyclin A2 induces myocardial regeneration and enhances cardiac function in ischemic heart failure. Circulation. 2006;114(suppl):I-206-I-213.
18. Sandritter W, Scomazzoni G. Desoxyribonucleic acid content (Feulgen photometry) and dry weight (interference microscopy) of normal and hypertrophic heart muscle fibers. Nature. 1964;202:100-101.
19. Sandritter W, Adler CP. Polyploidization of heart muscle nuclei as a prerequisite for heart growth and numerical hyperplasia in heart hypertrophy. Recent Adv Stud Cardiac Struct Metab. 1976;12:115-127.
20. Adler CP, Sandritter W. Alterations of substances (DNA, myoglobin, myosin, protein) in experimentally induced cardiac hypertrophy and under the influence of drugs (isoproterenol, cytostatics, strophanthin). Basic Res Cardiol. 1980;75:126-138.
21. Bergmann O, Bhardwaj RD, Bernard S, Zdunek S, Barnabe-Heider F, Walsh S, Zupicich J, Alkass K, Buchholz BA, Druid H, Jovinge S, Frisen J. Evidence for cardiomyocyte renewal in humans. Science. 2009;324: 98-102.
22. Busk PK, Bartkova J, Strom CC, Wulf-Andersen L, Hinrichsen R, Christ-offersen TE, Latella L, Bartek J, Haunso S, Sheikh SP. Involvement of cyclin D activity in left ventricle hypertrophy in vivo and in vitro. Cardiovasc Res. 2002;56:64-75.
23. Tea BS, Dam TV, Moreau P, Hamet P, deBlois D. Apoptosis during regression of cardiac hypertrophy in spontaneously hypertensive rats: temporal regulation and spatial heterogeneity. Hypertension. 1999;34: 229-235.
24. de Jonge N, van Wichen DF, van KJ, Kirkels H, Lahpor JR, Gmelig-Meyling FH, van den Tweel JG, de Weger RA. Cardiomyocyte death in patients with end-stage heart failure before and after support with a left ventricular assist device: low incidence of apoptosis despite ubiquitous mediators. J Heart Lung Transplant. 2003;22:1028-1036.
25. Flesch M, Margulies KB, Mochmann HC, Engel D, Sivasubramanian N, Mann DL. Differential regulation of mitogen-activated protein kinases in the failing human heart in response to mechanical unloading. Circulation. 2001;104:2273-2276.
26. Rumyantsev PP, Borisov A. DNA synthesis in myocytes from different myocardial compartments of young rats in norm, after experimental infarction and in vitro. Biomed Biochim Acta. 1987;46:S610-S615.
27. Baba HA, Stypmann J, Grabellus F, Kirchhof P, Sokoll A, Schafers M, Takeda A, Wilhelm MJ, Scheld HH, Takeda N, Breithardt G, Levkau B. Dynamic regulation of MEK/Erks and Akt/GSK-3beta in human end-stage heart failure after left ventricular mechanical support: myo-cardial mechanotransduction-sensitivity as a possible molecular mechanism. Cardiovasc Res. 2003;59:390-399.